Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Improving the stability of recombinant anthrax protective antigen vaccine.

Verma A, Burns DL.

Vaccine. 2018 Oct 15;36(43):6379-6382. doi: 10.1016/j.vaccine.2018.09.012. Epub 2018 Sep 15.

2.

Comparison of the immune response during acute and chronic Staphylococcus aureus infection.

Brady RA, Mocca CP, Plaut RD, Takeda K, Burns DL.

PLoS One. 2018 Mar 29;13(3):e0195342. doi: 10.1371/journal.pone.0195342. eCollection 2018.

3.

Role of the Antigen Capture Pathway in the Induction of a Neutralizing Antibody Response to Anthrax Protective Antigen.

Verma A, Ngundi MM, Price GA, Takeda K, Yu J, Burns DL.

MBio. 2018 Feb 27;9(1). pii: e00209-18. doi: 10.1128/mBio.00209-18.

4.

Towards replacement of the acellular pertussis vaccine safety test: Comparison of in vitro cytotoxic activity and in vivo activity in mice.

Wagner LD, Corvette LJ, Ngundi MM, Burns DL.

Vaccine. 2017 Dec 18;35(51):7160-7165. doi: 10.1016/j.vaccine.2017.10.082. Epub 2017 Nov 6.

5.

Mechanistic Analysis of the Effect of Deamidation on the Immunogenicity of Anthrax Protective Antigen.

Verma A, Ngundi MM, Burns DL.

Clin Vaccine Immunol. 2016 May 6;23(5):396-402. doi: 10.1128/CVI.00701-15. Print 2016 May.

6.

RNA-Seq Analysis of the Host Response to Staphylococcus aureus Skin and Soft Tissue Infection in a Mouse Model.

Brady RA, Bruno VM, Burns DL.

PLoS One. 2015 Apr 22;10(4):e0124877. doi: 10.1371/journal.pone.0124877. eCollection 2015.

7.

Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge.

Burns DL, Meade BD, Messionnier NE.

J Infect Dis. 2014 Apr 1;209 Suppl 1:S32-5. doi: 10.1093/infdis/jit491. Review. No abstract available.

PMID:
24626870
8.

Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations.

Farizo KM, Burns DL, Finn TM, Gruber MF, Pratt RD.

J Infect Dis. 2014 Apr 1;209 Suppl 1:S28-31. doi: 10.1093/infdis/jit532. Review.

PMID:
24626869
9.

Pertussis pathogenesis--what we know and what we don't know.

Hewlett EL, Burns DL, Cotter PA, Harvill ET, Merkel TJ, Quinn CP, Stibitz ES.

J Infect Dis. 2014 Apr 1;209(7):982-5. doi: 10.1093/infdis/jit639. Review.

10.
11.

Conservative management of small bowel perforation in Ehlers-Danlos syndrome type IV.

Allaparthi S, Verma H, Burns DL, Joyce AM.

World J Gastrointest Endosc. 2013 Aug 16;5(8):398-401. doi: 10.4253/wjge.v5.i8.398.

12.

Immunogenicity analysis of Staphylococcus aureus clumping factor A genetic variants.

Brady RA, Mocca CP, Burns DL.

Clin Vaccine Immunol. 2013 Aug;20(8):1338-40. doi: 10.1128/CVI.00275-13. Epub 2013 Jun 26.

13.

Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.

Brady RA, Mocca CP, Prabhakara R, Plaut RD, Shirtliff ME, Merkel TJ, Burns DL.

PLoS One. 2013 Apr 29;8(4):e63040. doi: 10.1371/journal.pone.0063040. Print 2013.

14.

Use of site-directed mutagenesis to model the effects of spontaneous deamidation on the immunogenicity of Bacillus anthracis protective antigen.

Verma A, McNichol B, Domínguez-Castillo RI, Amador-Molina JC, Arciniega JL, Reiter K, Meade BD, Ngundi MM, Stibitz S, Burns DL.

Infect Immun. 2013 Jan;81(1):278-84. doi: 10.1128/IAI.00863-12. Epub 2012 Oct 31.

15.

Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant.

Wagner L, Verma A, Meade BD, Reiter K, Narum DL, Brady RA, Little SF, Burns DL.

Clin Vaccine Immunol. 2012 Sep;19(9):1465-73. doi: 10.1128/CVI.00174-12. Epub 2012 Jul 18.

16.

Licensure of vaccines using the Animal Rule.

Burns DL.

Curr Opin Virol. 2012 Jun;2(3):353-6. doi: 10.1016/j.coviro.2012.01.004. Epub 2012 Jan 30.

PMID:
22709520
17.

Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition.

Burns DL, Gill BM.

JPEN J Parenter Enteral Nutr. 2013 Mar;37(2):274-80. doi: 10.1177/0148607112450301. Epub 2012 Jun 8.

PMID:
22683685
18.

Analysis of defined combinations of monoclonal antibodies in anthrax toxin neutralization assays and their synergistic action.

Ngundi MM, Meade BD, Little SF, Quinn CP, Corbett CR, Brady RA, Burns DL.

Clin Vaccine Immunol. 2012 May;19(5):731-9. doi: 10.1128/CVI.05714-11. Epub 2012 Mar 21.

19.

Low-protein diets for hepatic encephalopathy debunked: let them eat steak.

Cabral CM, Burns DL.

Nutr Clin Pract. 2011 Apr;26(2):155-9. doi: 10.1177/0884533611400086.

PMID:
21447768
20.

Analysis of antibody responses to protective antigen-based anthrax vaccines through use of competitive assays.

Brady RA, Verma A, Meade BD, Burns DL.

Clin Vaccine Immunol. 2010 Sep;17(9):1390-7. doi: 10.1128/CVI.00145-10. Epub 2010 Jul 14.

21.

Comparison of three anthrax toxin neutralization assays.

Ngundi MM, Meade BD, Lin TL, Tang WJ, Burns DL.

Clin Vaccine Immunol. 2010 Jun;17(6):895-903. doi: 10.1128/CVI.00513-09. Epub 2010 Apr 7.

22.

Analysis of the Fc gamma receptor-dependent component of neutralization measured by anthrax toxin neutralization assays.

Verma A, Ngundi MM, Meade BD, De Pascalis R, Elkins KL, Burns DL.

Clin Vaccine Immunol. 2009 Oct;16(10):1405-12. doi: 10.1128/CVI.00194-09. Epub 2009 Aug 5.

23.

The case for developing consensus standards for research in microbial pathogenesis: Bacillus anthracis toxins as an example.

Hughes MA, Burns DL, Juris SJ, Tang WJ, Clement KH, Eaton LJ, Kelly-Cirino CD, McKee ML, Powell BS, Bishop BL, Rudge TL, Shine N, Verma A, Willis MS, Morse SA.

Infect Immun. 2009 Oct;77(10):4182-6. doi: 10.1128/IAI.00368-09. Epub 2009 Aug 3. No abstract available.

24.

International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007.

Tondella ML, Carlone GM, Messonnier N, Quinn CP, Meade BD, Burns DL, Cherry JD, Guiso N, Hewlett EL, Edwards KM, Xing D, Giammanco A, Wirsing von König CH, Han L, Hueston L, Robbins JB, Powell M, Mink CM, Poolman JT, Hildreth SW, Lynn F, Morris A.

Vaccine. 2009 Feb 5;27(6):803-14. doi: 10.1016/j.vaccine.2008.11.072. Epub 2008 Dec 9.

PMID:
19071179
25.

Role of the N-terminal amino acid of Bacillus anthracis lethal factor in lethal toxin cytotoxicity and its effect on the lethal toxin neutralization assay.

Verma A, Wagner L, Stibitz S, Nguyen N, Guerengomba F, Burns DL.

Clin Vaccine Immunol. 2008 Nov;15(11):1737-41. doi: 10.1128/CVI.00081-08. Epub 2008 Sep 24.

26.

Stabilization of the pertussis toxin secretion apparatus by the C terminus of PtlD.

Verma A, Cheung AM, Burns DL.

J Bacteriol. 2008 Nov;190(21):7285-90. doi: 10.1128/JB.01106-08. Epub 2008 Aug 22.

27.

Successful algorithm for selective liver biopsy in the right hepatic lobe live donor (RHLD).

Simpson MA, Verbesey JE, Khettry U, Morin DS, Gordon FD, Burns DL, Robson K, Pomposelli JJ, Jenkins RL, Pomfret EA.

Am J Transplant. 2008 Apr;8(4):832-8. doi: 10.1111/j.1600-6143.2007.02135.x. Epub 2008 Feb 5.

28.

Supplementation of arachidonic acid plus docosahexaenoic acid in cirrhotic patients awaiting liver transplantation: a preliminary study.

Pazirandeh S, Ling PR, Ollero M, Gordon F, Burns DL, Bistrian BR.

JPEN J Parenter Enteral Nutr. 2007 Nov-Dec;31(6):511-6.

29.
30.

Severe ataxia, myelopathy, and peripheral neuropathy due to acquired copper deficiency in a patient with history of gastrectomy.

Tan JC, Burns DL, Jones HR.

JPEN J Parenter Enteral Nutr. 2006 Sep-Oct;30(5):446-50.

PMID:
16931615
31.

Nutrition support in the liver transplant patient.

Pomposelli JJ, Burns DL.

Nutr Clin Pract. 2002 Dec;17(6):341-9. No abstract available.

PMID:
16215010
32.
33.

Capsule endoscopy findings in celiac disease associated enteropathy-type intestinal T-cell lymphoma.

Joyce AM, Burns DL, Marcello PW, Tronic B, Scholz FJ.

Endoscopy. 2005 Jun;37(6):594-6.

PMID:
15933938
34.

Recurrent Clostridium difficile colitis.

Joyce AM, Burns DL.

Compr Ther. 2004 Fall-Winter;30(3):160-3. Review.

PMID:
15793316
35.
36.

Hypophosphatemia and the live liver donor.

Pomposelli JJ, Burns DL.

Transplantation. 2004 Jul 27;78(2):305. No abstract available.

PMID:
15280700
37.
38.

Type IV transporters of pathogenic bacteria.

Burns DL.

Curr Opin Microbiol. 2003 Feb;6(1):29-34. Review.

PMID:
12615216
39.

Recurrent Clostridium difficile colitis. Tackling a tenacious nosocomial infection.

Joyce AM, Burns DL.

Postgrad Med. 2002 Nov;112(5):53-4, 57-8, 65 passim.

PMID:
12462185
40.
41.

Life-threatening hypophosphatemia after right hepatic lobectomy for live donor adult liver transplantation.

Pomposelli JJ, Pomfret EA, Burns DL, Lally A, Sorcini A, Gordon FD, Lewis WD, Jenkins R.

Liver Transpl. 2001 Jul;7(7):637-42.

42.

Live donor adult liver transplantation using right lobe grafts: donor evaluation and surgical outcome.

Pomfret EA, Pomposelli JJ, Lewis WD, Gordon FD, Burns DL, Lally A, Raptopoulos V, Jenkins RL.

Arch Surg. 2001 Apr;136(4):425-33.

PMID:
11296114
43.

Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines.

Guiso N, Boursaux-Eude C, Weber C, Hausman SZ, Sato H, Iwaki M, Kamachi K, Konda T, Burns DL.

Vaccine. 2001 Apr 30;19(23-24):3248-52.

PMID:
11312021
44.

Renaming protein secretion in the gram-negative bacteria.

Henderson IR, Nataro JP, Kaper JB, Meyer TF, Farrand SK, Burns DL, Finlay BB, St Geme JW 3rd.

Trends Microbiol. 2000 Aug;8(8):352. No abstract available.

PMID:
11041650
45.

Renaming protein secretion in the gram-negative bacteria

Henderson IR, Nataro JP, Kaper JB, Meyer TF, Farrand SK, Burns DL, Finlay BB, St Geme JW 3rd.

Trends Microbiol. 2000 Aug;8(8):352. No abstract available.

PMID:
10920393
46.
48.

Healthy Minnesotans. A goal we all share.

Burns DL, Stroud DP.

Minn Med. 1999 Dec;82(12):55-8. No abstract available.

PMID:
10635681
49.

Toxicity of parenteral iron dextran therapy.

Burns DL, Pomposelli JJ.

Kidney Int Suppl. 1999 Mar;69:S119-24. Review.

PMID:
10084295
50.

Biochemistry of type IV secretion.

Burns DL.

Curr Opin Microbiol. 1999 Feb;2(1):25-9. Review.

PMID:
10047550

Supplemental Content

Loading ...
Support Center